Document Detail


Continuation of antibiotics is associated with failure of metronidazole for Clostridium difficile-associated diarrhea.
MedLine Citation:
PMID:  16340634     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
BACKGROUND: Metronidazole is first-line therapy for C. difficile-associated diarrhea primarily because of its low cost relative to vancomycin. Currently, it is unknown which patients will fail metronidazole therapy. Our goal was to prospectively evaluate risk factors for metronidazole failure. STUDY: Included patients had symptomatic C. difficile-associated diarrhea, either mild or severe. Once enrolled, detailed baseline data were gathered. All interviews were performed daily while the patient was in the hospital for up to 14 days. If discharged prior to 14 days, the patient received a follow-up phone call on day 5 and day 14. Enrolled patients were given a daily stool survey to complete. RESULTS: We enrolled 27 patients with C. difficile-associated diarrhea. All patients (10 of 10) who had their offending antibiotic(s) discontinued had symptomatic resolution of diarrhea by day 14 of metronidazole treatment. Conversely, 59% (10 of 17) of patients who remained on antibiotics during treatment had symptomatic resolution by day 14 (P=0.02). The risk ratio for treatment failure was 2.0 (95% confidence interval, 1.29-3.10) in patients who remained on antibiotics. In our treatment group, there would be one additional metronidazole treatment success for every 2.4 patients who discontinued antibiotics. CONCLUSION: Patients who remain on antibiotics while undergoing treatment of C. difficile-associated diarrhea have a high likelihood of treatment failure with metronidazole.
Authors:
Scott Modena; Satya Gollamudi; Frank Friedenberg
Related Documents :
20601414 - Novel approach to antibiotic prophylaxis in percutaneous endoscopic gastrostomy (peg): ...
3892854 - Role of piperacillin in surgical prophylaxis of genitourinary infections.
3184334 - Prevention of recurrent staphylococcal skin infections with low-dose oral clindamycin t...
8793464 - Effect of long-term primary aerosolized pentamidine prophylaxis on breakthrough pneumoc...
18484894 - Partial nephrectomy using renal artery perfusion for cold ischemia: functional and onco...
22299124 - The effect of nitradine on the candida levels of maxillary removable appliances.
Publication Detail:
Type:  Journal Article    
Journal Detail:
Title:  Journal of clinical gastroenterology     Volume:  40     ISSN:  0192-0790     ISO Abbreviation:  J. Clin. Gastroenterol.     Publication Date:  2006 Jan 
Date Detail:
Created Date:  2005-12-12     Completed Date:  2006-03-16     Revised Date:  2007-11-15    
Medline Journal Info:
Nlm Unique ID:  7910017     Medline TA:  J Clin Gastroenterol     Country:  United States    
Other Details:
Languages:  eng     Pagination:  49-54     Citation Subset:  IM    
Affiliation:
Section of Gastroenterology, Temple University Hospital, Philadelphia, PA 19140, USA.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Aged
Aged, 80 and over
Anti-Infective Agents / adverse effects*,  therapeutic use*
Chi-Square Distribution
Clostridium Infections / drug therapy*
Clostridium difficile*
Diarrhea / drug therapy*,  microbiology*
Female
Humans
Interviews as Topic
Male
Metronidazole / therapeutic use*
Middle Aged
Prospective Studies
Risk Factors
Severity of Illness Index
Statistics, Nonparametric
Treatment Failure
Chemical
Reg. No./Substance:
0/Anti-Infective Agents; 443-48-1/Metronidazole

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Histologic study of colonic mucosa in patients with chronic diarrhea and normal colonoscopic finding...
Next Document:  Treatment with infliximab is associated with increased markers of bone formation in patients with Cr...